Split-Dose PEG Sulfate Colon Cleansing for Electrolyte Safety

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Existing bowel preparations for colon cleansing, such as those based on polyethylene glycol (PEG) and sulfate, suffer from patient discomfort, poor compliance, electrolyte imbalances, and safety concerns, including renal issues and hyponatremia, while requiring adjunct laxatives like bisacodyl.

Innovation Solution

A composition comprising PEG, sodium sulfate, magnesium sulfate, potassium chloride, and sodium chloride, balanced with flavoring agents and non-fermentable sugars, is administered in split doses to effectively cleanse the colon without adjunct laxatives, maintaining electrolyte balance and improving taste.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If large volume PEG-based preparations are used for colon cleansing, then patient safety is improved, but patient compliance deteriorates due to large volume consumption requirement

Engineering Contradiction:
Improvepatient safetyVSAvoidpatient compliance
Core Design Contradiction:
ReliabilityVSEase of operation

Solution Approach 1:

The bowel preparation is divided into two separate doses administered at different times (first dose the evening before procedure, second dose the morning of procedure). This segmentation allows patients to consume smaller volumes at each administration, improving compliance while maintaining the safety benefits of adequate PEG-based cleansing

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The formulation uses isotonic PEG-based solution with specific electrolyte composition (sodium, potassium, magnesium, calcium) to maintain osmotic balance. This parameter optimization ensures safety through proper electrolyte replacement while the divided dosing schedule addresses the volume compliance issue

Inventive Principle:
Principle #35Parameter changes

2Ease of operation

If hypertonic solutions are used to reduce volume, then patient compliance improves, but safety deteriorates due to electrolyte imbalances and renal issues

Engineering Contradiction:
Improvepatient complianceVSAvoidpatient safety
Core Design Contradiction:
Ease of operationVSReliability

Solution Approach 1:

The solution is formulated as isotonic rather than hypertonic, with carefully balanced electrolyte concentrations (sodium, potassium, magnesium, calcium) to match physiological levels. This parameter optimization prevents electrolyte imbalances and renal complications while maintaining patient compliance through acceptable taste and tolerability

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The formulation replicates physiological electrolyte composition found in body fluids, creating an isotonic solution that mimics natural bodily fluids. This copying of physiological parameters ensures safety by preventing electrolyte disturbances while maintaining compliance through reduced gastrointestinal discomfort

Inventive Principle:
Principle #26Copying

3Productivity

If phosphate-based preparations are used, then bowel cleansing efficacy improves, but safety deteriorates due to renal calcium phosphate deposition

Engineering Contradiction:
Improvebowel cleansing efficacyVSAvoidpatient safety
Core Design Contradiction:
ProductivityVSReliability

Solution Approach 1:

The phosphate component is completely removed from the formulation and replaced with sulfate-based osmotic agents (magnesium sulfate, sodium sulfate). This extraction of the harmful phosphate element maintains bowel cleansing efficacy through osmotic action while eliminating the risk of renal calcium phosphate deposition

Inventive Principle:
Principle #2Taking out (Extraction)

Solution Approach 2:

The formulation uses readily available sulfate salts (magnesium sulfate, sodium sulfate) as safe alternatives to phosphate. These substances provide effective osmotic cleansing without the long-term safety concerns of phosphate accumulation, offering a disposable-safe solution for bowel preparation

Inventive Principle:
Principle #27Cheap short-living objects (Disposable)

4Productivity

If stimulant laxatives are added to PEG-based preparations, then bowel cleansing efficacy improves, but safety deteriorates due to side effects and compliance issues

Engineering Contradiction:
Improvebowel cleansing efficacyVSAvoidpatient safety
Core Design Contradiction:
ProductivityVSReliability

Solution Approach 1:

Stimulant laxatives (such as bisacodyl) are completely removed from the formulation. The bowel cleansing efficacy is achieved solely through the osmotic action of PEG and sulfate salts, eliminating side effects associated with stimulant laxatives including cramps, bloating, and electrolyte disturbances

Inventive Principle:
Principle #2Taking out (Extraction)

Solution Approach 2:

The PEG-based isotonic solution with sulfate salts provides self-service bowel cleansing through osmotic action that draws water into the bowel lumen and promotes natural peristalsis. This eliminates the need for external stimulant laxatives, providing safe and effective cleansing through the preparation's own mechanism

Inventive Principle:
Principle #25Self-service

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The composition achieves substantial stool output, reduces gas production, and avoids clinically significant electrolyte shifts, ensuring patient safety and compliance, making it suitable for diagnostic and surgical procedures.

Implementation Method 1

The composition comprises polyethylene glycol, sulfate, and balanced electrolytes... induces purgation... substantial stool output

Methodology Applied
Scientific EffectOsmosis: Osmosis

Implementation Method 2

a PEG-based product could be provided with a flavoring agent comprising acidic components such that the PEG was not degraded to yield byproducts

Methodology Applied
Scientific EffectChemical stability:

Data Source

PatentUS12594298B2Methods of administering safe colon cleansing compositions
Publication Date: 2026.04.07 AZURITY PHARMA INC

AI summary

Disclosed herein are methods of administering compositions comprising a mixture of salts that induce purgation of the colon and are useful to cleanse the colon. Furthermore, the disclosed methods prevent degradation of PEG and allow for cleansing of the colon without the use of adjunct laxatives, including stimulant laxatives such as bisacodyl. The disclosed methods are superior to the prior art in that they allow for higher tolerability, improved safety, lower volumes, and improved patient compliance.